13417-73-7

Upstream product

• 33257-83-9 4-(4-hydroxyphenyl)-7-methoxy-3-phenyl-2H-chromen-2-one 

Downstream Products

• 207278-54-4 (+)-cis-7-Methoxy-3-phenyl-4-{4-{2-(pyrrolidin-1-yl)ethoxy}phenyl}chromane 
• 207277-66-5 (-)-cis-7-Hydroxy-3-phenyl-4-(4-(2-pyrrolidinoethoxy)phenyl)chromane 
• 18196-29-7 (3R,4S)-7-methoxy-3-phenyl-4-(4-(2-pyrrolidinoethoxy)phenyl)chromane 
• 18196-29-7 (+/-)-cis-7-methoxy-3-phenyl-4-(4-(2-pyrrolidinoethoxy)phenyl)chromane 

Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of novel cis-3,4-Diaryl-hydroxychromanes as high affinity partial agonists for the estrogen receptor

The syntheses and in vitro pharmacological evaluation of a number of cis-3,4-diaryl-hydroxy-chromanes are reported, along with the results of a thorough in vivo profiling of the tissue-selective estrogen partial-agonist NNC 45-0781 [3, (-)-(3S,4R)-7-hydro

Smooth Conversion of 3,4-Diarylcoumarins and 3,4,5-Triaryl-2(5H)-furanones to 2H-Chromene and 2,5-Dihydrofuran Derivatives with Dimethyl Sulfide-Borane Complex

Reaction of 3,4-diarylcoumarins (3,4-diaryl-2-oxo-2H-1-benzopyrans) and 3,4,5-triaryl-2(5H)-furanones with dimethyl sulfide-borane complex affords the corresponding 2H-chromenes (2H-1-benzopyrans) and 2,5-dihydrofurans in high yields. 3,4-Diaryl-2(5H)-fur